Home › Blastic Plasmacytoid Dendritic Cell Cancer › Texas

Pag-aaral pangklinika para sa Blastic Plasmacytoid Dendritic Cell Cancer sa Texas

3 pag-aaral para sa Blastic Plasmacytoid Dendritic Cell Cancer ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Houston3 pag-aaral

Opisyal na teksto ng pag-aaral (English)

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M D Anderson Cancer Center, Houston

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04216524

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

MD Anderson Cancer Center, Houston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT03113643

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

University of Texas, Southwestern, Dallas
Cook Children's Hospital, Fort Worth
Texas Children's Hospital/Baylor College of Medicine, Houston

Nagre-recruitPhase 1

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.